Fernández-de-las-Peñas, C.; Franco-Moreno, A.; Ruiz-Ruigómez, M.; Arrieta-Ortubay, E.; Ryan-Murua, P.; Lumbreras-Bermejo, C.; del-Valle-Loarte, P.; Pellicer-Valero, O.J.; Torres-Macho, J.; Giordano, R.;
et al. Intravenous Administration of Remdesivir at the Acute Phase of SARS-CoV-2 Infection Is Associated with a Lower Prevalence of Post-COVID-19 Pain. J. Clin. Med. 2025, 14, 3156.
https://doi.org/10.3390/jcm14093156
AMA Style
Fernández-de-las-Peñas C, Franco-Moreno A, Ruiz-Ruigómez M, Arrieta-Ortubay E, Ryan-Murua P, Lumbreras-Bermejo C, del-Valle-Loarte P, Pellicer-Valero OJ, Torres-Macho J, Giordano R,
et al. Intravenous Administration of Remdesivir at the Acute Phase of SARS-CoV-2 Infection Is Associated with a Lower Prevalence of Post-COVID-19 Pain. Journal of Clinical Medicine. 2025; 14(9):3156.
https://doi.org/10.3390/jcm14093156
Chicago/Turabian Style
Fernández-de-las-Peñas, César, Anabel Franco-Moreno, MarÃa Ruiz-Ruigómez, Estibaliz Arrieta-Ortubay, Pablo Ryan-Murua, Carlos Lumbreras-Bermejo, Pablo del-Valle-Loarte, Oscar J. Pellicer-Valero, Juan Torres-Macho, Rocco Giordano,
and et al. 2025. "Intravenous Administration of Remdesivir at the Acute Phase of SARS-CoV-2 Infection Is Associated with a Lower Prevalence of Post-COVID-19 Pain" Journal of Clinical Medicine 14, no. 9: 3156.
https://doi.org/10.3390/jcm14093156
APA Style
Fernández-de-las-Peñas, C., Franco-Moreno, A., Ruiz-Ruigómez, M., Arrieta-Ortubay, E., Ryan-Murua, P., Lumbreras-Bermejo, C., del-Valle-Loarte, P., Pellicer-Valero, O. J., Torres-Macho, J., Giordano, R., & Arendt-Nielsen, L.
(2025). Intravenous Administration of Remdesivir at the Acute Phase of SARS-CoV-2 Infection Is Associated with a Lower Prevalence of Post-COVID-19 Pain. Journal of Clinical Medicine, 14(9), 3156.
https://doi.org/10.3390/jcm14093156
